| Product Code: ETC7548300 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Motor Neurone Disease (MND) Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Motor Neurone Disease (MND) Market Revenues & Volume, 2021 & 2031F |
3.3 India Motor Neurone Disease (MND) Market - Industry Life Cycle |
3.4 India Motor Neurone Disease (MND) Market - Porter's Five Forces |
3.5 India Motor Neurone Disease (MND) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Motor Neurone Disease (MND) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 India Motor Neurone Disease (MND) Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 India Motor Neurone Disease (MND) Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.9 India Motor Neurone Disease (MND) Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 India Motor Neurone Disease (MND) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of motor neurone disease (MND) in India |
4.2.2 Advancements in medical research leading to better treatment options |
4.2.3 Growing healthcare infrastructure and facilities in India |
4.3 Market Restraints |
4.3.1 Limited availability and affordability of specialized MND treatments |
4.3.2 Lack of skilled healthcare professionals with expertise in managing MND cases |
5 India Motor Neurone Disease (MND) Market Trends |
6 India Motor Neurone Disease (MND) Market, By Types |
6.1 India Motor Neurone Disease (MND) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Motor Neurone Disease (MND) Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Motor Neurone Disease (MND) Market Revenues & Volume, By Amyotrophic lateral sclerosis (ALS), 2021- 2031F |
6.1.4 India Motor Neurone Disease (MND) Market Revenues & Volume, By Progressive bulbar palsy (PBP), 2021- 2031F |
6.1.5 India Motor Neurone Disease (MND) Market Revenues & Volume, By Progressive muscular atrophy (PMA), 2021- 2031F |
6.1.6 India Motor Neurone Disease (MND) Market Revenues & Volume, By Primary lateral sclerosis (PLS), 2021- 2031F |
6.2 India Motor Neurone Disease (MND) Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 India Motor Neurone Disease (MND) Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 India Motor Neurone Disease (MND) Market Revenues & Volume, By Physiotherapy, 2021- 2031F |
6.2.4 India Motor Neurone Disease (MND) Market Revenues & Volume, By Palliative Care, 2021- 2031F |
6.2.5 India Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Motor Neurone Disease (MND) Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 India Motor Neurone Disease (MND) Market Revenues & Volume, By Blood test, 2021- 2031F |
6.3.3 India Motor Neurone Disease (MND) Market Revenues & Volume, By Electromyography (EMG), 2021- 2031F |
6.3.4 India Motor Neurone Disease (MND) Market Revenues & Volume, By MRI Scan, 2021- 2031F |
6.3.5 India Motor Neurone Disease (MND) Market Revenues & Volume, By Transcranial magnetic stimulation (TMS), 2021- 2031F |
6.3.6 India Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Motor Neurone Disease (MND) Market, By Dosage |
6.4.1 Overview and Analysis |
6.4.2 India Motor Neurone Disease (MND) Market Revenues & Volume, By Tablet, 2021- 2031F |
6.4.3 India Motor Neurone Disease (MND) Market Revenues & Volume, By Injection, 2021- 2031F |
6.4.4 India Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Motor Neurone Disease (MND) Market, By End users |
6.5.1 Overview and Analysis |
6.5.2 India Motor Neurone Disease (MND) Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 India Motor Neurone Disease (MND) Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5.4 India Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
7 India Motor Neurone Disease (MND) Market Import-Export Trade Statistics |
7.1 India Motor Neurone Disease (MND) Market Export to Major Countries |
7.2 India Motor Neurone Disease (MND) Market Imports from Major Countries |
8 India Motor Neurone Disease (MND) Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for MND patients in India |
8.2 Number of clinical trials and research studies focused on MND in India |
8.3 Percentage of MND patients receiving timely and appropriate treatment and care |
9 India Motor Neurone Disease (MND) Market - Opportunity Assessment |
9.1 India Motor Neurone Disease (MND) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Motor Neurone Disease (MND) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 India Motor Neurone Disease (MND) Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 India Motor Neurone Disease (MND) Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.5 India Motor Neurone Disease (MND) Market Opportunity Assessment, By End users, 2021 & 2031F |
10 India Motor Neurone Disease (MND) Market - Competitive Landscape |
10.1 India Motor Neurone Disease (MND) Market Revenue Share, By Companies, 2024 |
10.2 India Motor Neurone Disease (MND) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here